SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001636050-20-000091
Filing Date
2020-11-13
Accepted
2020-11-13 07:02:22
Documents
60
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q siox-20200930.htm   iXBRL 10-Q 1373421
2 EX-4.1 exhibit41-formofstockcer.htm EX-4.1 9240
3 EX-31.1 a093020exhibit3111.htm EX-31.1 10491
4 EX-31.2 a093020exhibit3121.htm EX-31.2 10581
5 EX-32.1 a093020exhibit3211.htm EX-32.1 5999
6 EX-32.2 a093020exhibit3221.htm EX-32.2 5983
12 GRAPHIC exhibit41-formofstockcer001.jpg GRAPHIC 182634
13 GRAPHIC exhibit41-formofstockcer002.jpg GRAPHIC 102776
14 GRAPHIC siox-20200930_g1.jpg GRAPHIC 44055
  Complete submission text file 0001636050-20-000091.txt   5324894

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT siox-20200930.xsd EX-101.SCH 33721
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT siox-20200930_cal.xml EX-101.CAL 53492
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT siox-20200930_def.xml EX-101.DEF 195277
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT siox-20200930_lab.xml EX-101.LAB 424475
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT siox-20200930_pre.xml EX-101.PRE 283971
15 EXTRACTED XBRL INSTANCE DOCUMENT siox-20200930_htm.xml XML 491220
Mailing Address 11 TIMES SQUARE 33RD FLOOR NEW YORK NY 10036
Business Address 11 TIMES SQUARE 33RD FLOOR NEW YORK NY 10036 877-746-4891
Axovant Gene Therapies Ltd. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 981333697 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37418 | Film No.: 201309133
SIC: 2834 Pharmaceutical Preparations